What's New

Introductions to the latest additions to the AMS website are shown here.

Members should log in to see the Members's only content on this page. 

  • Cervical screening participation rates - what influences them
    The impression that foreign-born women in Sweden more often are excluded from gynecological cancer screening needs to be reconsidered. A study from Sahlgrenska Academy, published in the journal PLOS One, makes it clear that foreign-born women participate to the same extent as women born in Sweden wi... Read more.
  • Increased risk of heart disease after hysterectomy
    In an effort to reduce the associated increased risk of heart disease after hysterectomy, more surgeons are opting to leave a woman's ovaries intact. However, a study shows that women (especially those aged younger than 35 years) having a hysterectomy with ovarian conservation are still at increased... Read more.
  • Heavy Menstrual Bleeding Clinical Care Standard launched
    7 December 2017:  Women to benefit from first national treatment standard for heavy periods  The first nationally agreed standard of care for women experiencing heavy menstrual bleeding says women should be offered less invasive treatments before considering a hysterectomy – a major op... Read more.
  • Oestrogen patch update - supply returned
    30 November 2017:  Novartis has advised that the company has both received and released stock for supply locally of the following lines; ESTALIS CONT 50+140MCG  ESTALIS SEQ 50MCG/50+ 140MCG  ESTALIS SEQ 50MCG/50+ 250MCG As a result the only remaining HRT line now still u... Read more.
  • Women's memory may benefit from hormone replacement therapy
    A type of hormone replacement therapy may protect memory for some women, according to an American study. The research findings are the latest to indicate that hormone replacement therapy may have some benefits, deepening scientific discussions about the pros and cons of the menopausal treatment. "... Read more.
  • Discontinuing hormone therapy increases risk of cardiac and stroke death
    Hormone therapy (HT) continues to be a hotly debated topic. The benefits of estrogen to the heart, however, appear to be universally accepted. A European study demonstrates that the risk of cardiac and stroke death actually increases in the first year after discontinuation of HT. Since publication ... Read more.
  • Postmenopausal obesity redefined
    BMI may not be valid measure of obesity status in older adults There is no doubt the prevalence of obesity has increased significantly across all age groups, creating greater health risks. What exactly constitutes obesity, however, is subject to debate, especially for postmenopausal women who ... Read more.
  • Prasterone (Intrarosa) for Dyspareunia
    From the Medical Letter The FDA has approved the steroid prasterone (Intrarosa – Endoceutics) for intravaginal treatment of postmenopausal women with moderate-to-severe dyspareunia due to vulvovaginal atrophy (VVA) (Table 1). Also called dehydroepiandrosterone (DHEA), prasterone is produced in the ... Read more.
  • Bioidentical Hormones - risks revisited
    The October issue of Endocrine news (1) carries an article that once again tackles the complexity of bioidentical hormones. The freelance US writer highlights the confusion surrounding "bioidentical hormones" and more specifically the compounded formulations that are promoted as "natural". Th... Read more.
  • Cognitive Concerns
    Dr Victor Henderson Past President, The North American Menopause Society Professor, Health Research and Policy and Neurology and Neurological Sciences Stanford University Director, Alzheimer’s Disease Research Center Stanford, CA Dr Hendersen discusses cognitive changes during menopause and when t... Read more.
  • Why some women are more likely to feel depressed
    Study links duration of estrogen exposure with increased vulnerability to depression: Longer exposure to estrogen shown to provide protection It's no secret that the risk of depression increases for women when their hormones are fluctuating. Especially vulnerable times include the menopause transit... Read more.
  • Early menopause is independently linked to an increased risk of developing type 2 diabetes
    Women with early or normal onset menopause are at a higher risk of developing type 2 diabetes than those with late onset menopause, concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes). Previous research (by the same authors of this ne... Read more.
  • Eating more vegetable protein may protect against early menopause
    Study shows modest but significant lower risk Results of a new study from epidemiologists at the University of Massachusetts Amherst and Harvard T.H. Chan School of Public Health suggest that long-term, high intake of vegetable protein from such foods as whole grains, soy and tofu, may protect wome... Read more.
  • Knowledge and attitudes of health professionals regarding menopausal hormone therapies
    Objective:  To evaluate the knowledge and attitudes of Australian health professionals (HPs) including general practitioners (GPs), gynecologists and endocrinologists, to menopausal hormone therapy (MHT). Methods:  Participants were recruited from medical societies/colleges and a nation... Read more.
  • Management of aromatase inhibitor-associated bone loss in postmenopausal women
    17 July, 2017:  Several guidelines have been reported for bone-directed treatment in women with early breast cancer for averting fractures, particularly during aromatase inhibitor (AI) therapy. A systematic literature review identified both several fracture-related risk factors as well as rece... Read more.
  • Breast density, breast cancer risk, and hormone therapy
    10 July, 2017:  The radiographic appearance of the breast on mammography varies among women. Fat appears dark on a mammogram, whereas connective and epithelial tissues are radiologically dense and appear white. This is the basis for determining the mammographic density, and the relative percen... Read more.
  • Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis
    This review in 2016 of 62 studies suggests that some plant-based therapies are associated with modest reductions in the frequency of hot flushes and vaginal dryness but no significant reduction in night sweats.  Abstract Importance: Between 40% and 50% of women in Western countries use com... Read more.
  • NAMS 2017 position statement updates guidelines for hormone therapy use
    A new position statement on the use of hormone therapy (HT) for menopausal and postmenopausal women from The North American Menopause Society (NAMS) has been published online today in the Society's journal, Menopause. "The use of hormone therapy continues to be one of the most controversial and deba... Read more.
  • A new look at hormone therapy and dementia
    26 June 2017:  Mikkola and colleagues examined the association between use of hormone therapy (HT) and death from Alzheimer’s disease (AD) or vascular dementia (VaD) in a sample of 489,105 Finnish women who had documented use of systemic HT on a nationwide drug reimbursement register [1]. A na... Read more.
  • Neurokinin-3 receptor antagonist to treat hot flushes
    8 May, 2017:  Hot flushes, which are among the most frequent symptoms of menopause, are considered to be the result of the changes in the sex hormone milieu and tissue exposure at midlife and beyond. However, modern medicine tries also to tie physiological processes with the individual gene pr... Read more.